GeneSegues, Inc. Appoints New SAB Member  
10/19/2005 5:09:29 PM

GeneSegues, Inc., a biopharmaceutical company that develops nanoencapsulated therapeutics, today announced the appointment of Dr. Erkki Ruoslahti, Ph.D., M.D., to its Scientific Advisory Board (SAB). Dr. Ruoslahti holds the position of Distinguished Professor at the Burnham Institute in La Jolla, California.